Catabasis

Learn More

Enrollment will begin soon in 2018 for our Phase 3 PolarisDMD trial with edasalonexent in Duchenne muscular dystrophy.

Patients & Families

We are honored and proud to be members of the Duchenne muscular dystrophy (DMD) community – one that is built on strength and determination.

A potential foundational therapy aimed at improving the lives of all affected by Duchenne.

One Kendall Square, Bldg. 1400E, Suite B14202, Cambridge, MA 02139 617-349-1971 info@catabasis.com

One Kendall Square, Bldg. 1400E, Suite B14202, Cambridge, MA 02139

617-349-1971

info@catabasis.com